Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Press

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomasM F Press, L Bernstein, P A Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trialJ R Mackey, T Pieńkowski, J Crown, et al.
British Journal of Cancer|August 5, 2005
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histologyG Ursin, L Bernstein, S J Lord, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP Tarantino, G Viale, M F Press, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomasM F Press, L Bernstein, P A Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2016
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trialJ R Mackey, T Pieńkowski, J Crown, et al.
British Journal of Cancer|August 5, 2005
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histologyG Ursin, L Bernstein, S J Lord, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP Tarantino, G Viale, M F Press, et al.
Pageof 8